Insulin resistance in the brains of individuals with Alzheimer’s disease (AD) has been hypothesised, but its existence, causes and consequences have not been established. Talbot et al. now provide evidence that dysregulated insulin signalling in the brain is a common and early event in AD. They measured insulin signalling pathway activation in post-mortem human brain samples (in which functional signalling is maintained for several hours after death), focusing on the cerebellar cortex (CC), which exhibits pathology in late-stage AD, and the hippo-campal formation (HF), which exhibits pathology in early-stage AD and is associated with cognitive decline. Compared with normal controls, activation of insulin signalling intermediates was lower in AD brains, especially in the HF. Insulin resistance was specifically associated with dysfunctional insulin receptor substrate 1 (IRS-1). The authors also identified two phosphorylated forms of IRS-1 (IRS-1pS616 and IRS-1pS636/639) as candidate biomarkers of brain insulin resistance and show that they are elevated in the HF of individuals with AD even without a history of diabetes. Finally, they show that both potential biomarkers are negatively correlated with cognitive function. These data strengthen the hypo thesis that brain insulin resistance contributes to the pathology of AD and indicate new avenues for prevention or therapy.
Brain insulin resistance in Alzheimer’s disease
Brain insulin resistance in Alzheimer’s disease. Dis Model Mech 1 May 2012; 5 (3): 287. doi:
Download citation file:
Advertisement
Cited by
Call for Papers – Infectious Disease: Evolution, Mechanisms and Global Health

Showcase your latest research on our upcoming Special Issue: Infectious Disease: Evolution, Mechanisms and Global Health. This issue will be coordinated by DMM Editors Sumana Sanyal and David Tobin alongside Guest Editors Judi Allen and Russell Vance. The deadline for submitting articles to this Special Issue has been extended to Monday 24 February 2025.
Biologists @ 100 - join us in Liverpool in March 2025

We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate a DMM programme on antimicrobial resistance on 26 March 2025. Find out more and register to join us in March 2025 in Liverpool, UK. The final deadline to register is 28 February 2025.
It's about time: the heterochronic background for the 2024 Nobel Prize in Physiology or Medicine

In this Editorial, Bruce Wightman writes about the groundwork laid by investigating the timing of developmental events in nematodes which led to the 2024 Nobel Prize in Physiology or Medicine.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Other journals from
The Company of Biologists